Additionally, to delve deeper into the impact of NDUFAF6 on the prognosis of patients at varying stages of BC, our investigation revealed that NDUFAF6 remains a viable prognostic indicator in BC stages T1&T2, M0, as well as Stage I&Stage II. This evidence concerns the gene NDUFAF6 and breast cancer.